当前位置: X-MOL 学术Immun. Inflamm. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials
Immunity, Inflammation and Disease ( IF 3.1 ) Pub Date : 2020-11-26 , DOI: 10.1002/iid3.374
Alberto Enrico Maraolo 1 , Adriano Grossi 2
Affiliation  

Hydroxycloroquine (HCQ) has been extensively studied for treatment and prevention of coronavirus diseases 2019 (COVID‐19) from the start of the pandemic. Conflicting evidence about its usefulness has begun to accrue.

中文翻译:

羟氯喹治疗或预防 SARS-CoV-2 感染的安全性:随机临床试验的快速系统评价和荟萃分析

自大流行开始以来,羟基氯喹 (HCQ) 已被广泛研究用于治疗和预防 2019 年冠状病毒疾病 (COVID-19)。关于其有用性的相互矛盾的证据已经开始出现。
更新日期:2021-02-04
down
wechat
bug